Judith Balmañà

2002–2026 年に発表

別表記
Judith Balmaña
114
論文数
18,288
被引用数
63
h 指数
106
i10 指数

被引用数

Judith Balmañà の年別被引用数1996 年: 被引用 1 件1998 年: 被引用 2 件2004 年: 被引用 1 件2005 年: 被引用 2 件2007 年: 被引用 6 件2008 年: 被引用 5 件2009 年: 被引用 8 件2010 年: 被引用 18 件2011 年: 被引用 16 件2012 年: 被引用 16 件2013 年: 被引用 60 件2014 年: 被引用 78 件2015 年: 被引用 110 件2016 年: 被引用 146 件2017 年: 被引用 173 件2018 年: 被引用 191 件2019 年: 被引用 612 件2020 年: 被引用 867 件2021 年: 被引用 903 件2022 年: 被引用 845 件2023 年: 被引用 603 件2024 年: 被引用 1,012 件2025 年: 被引用 568 件2026 年: 被引用 20 件1997 年は被引用が無いため表示していません1999〜2003 年は被引用が無いため表示していません2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,975 件、この内訳の 18.7%中国: 引用元論文 826 件、この内訳の 7.8%イギリス: 引用元論文 812 件、この内訳の 7.7%イタリア: 引用元論文 639 件、この内訳の 6.1%ドイツ: 引用元論文 492 件、この内訳の 4.7%スペイン: 引用元論文 490 件、この内訳の 4.7%カナダ: 引用元論文 425 件、この内訳の 4%フランス: 引用元論文 414 件、この内訳の 3.9%オーストラリア: 引用元論文 390 件、この内訳の 3.7%オランダ: 引用元論文 325 件、この内訳の 3.1%スウェーデン: 引用元論文 227 件、この内訳の 2.2%ベルギー: 引用元論文 203 件、この内訳の 1.9%
0%18.7%その他 31.5%

分野

  • Medicine56%
  • Biochemistry, Genetics and Molecular Biology40.5%
  • Immunology and Microbiology0.9%
  • Computer Science0.6%
  • Agricultural and Biological Sciences0.3%
  • Chemistry0.3%
  • その他1.4%

トピック

  • PARP inhibition in cancer therapy10.2%
  • BRCA gene mutations in cancer7.7%
  • DNA Repair Mechanisms6.3%
  • Cancer Genomics and Diagnostics5.1%
  • Genetic factors in colorectal cancer4.4%
  • Ovarian cancer diagnosis and treatment3.4%
  • その他62.9%

共著者

全論文

検索で開く
  1. Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer - New England Journal of Medicine 2021 被引用: 1,665

  2. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sunil R. Lakhani, W Janni, Barbro Linderholm, T.-W. Liu, Niklas Loman, Larissa A. Korde, Sibylle Loibl, Peter C. Lucas, Frederik Marmé, E. Martinez de Dueñas, Robin McConnell, Kelly‐Anne Phillips, Martine Piccart, Giovanna Rossi, Rita K. Schmutzler, Elżbieta Senkus, Zhi-Ming Shao, Priyanka Sharma, Christian F. Singer, Tanja Španić, Elmar Stickeler, Masakazu Toi, Tiffany A. Traina, Giuseppe Viale, Gabriele Zoppoli, Y.H. Park, Rinat Yerushalmi, Huan Yang, D. Pang, Kyung Hae Jung, Audrey Mailliez, Zhaoqing Fan, Isabelle Tennevet, J. Zhang, T. Nagy, Gabe S. Sonke, Qiuhong Sun, Marina Parton, Marco Colleoni, Marcus Schmidt, Adam Brufsky, W. Razaq, Bella Kaufman, David Cameron, Christine Campbell, Andrew Tutt, P. Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, A. Weltermann, Daniel Egle, I. Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser‐Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke ほか 509 名 - Annals of Oncology 2022 被引用: 447

  3. A decade of clinical development of PARP inhibitors in perspective

    著者: , , , , , , , , , - Annals of Oncology 2019 被引用: 730

  4. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elaine Cadogan, J. Carl Barrett, Carlos Caldas, José Baselga, Cristina Saura, Javier Cortés, Joaquı́n Arribas, Jos Jonkers, Orland Dı́ez, Mark J. O’Connor, Judith Balmañà, Violeta Serra - Annals of Oncology 2018 被引用: 427

  5. Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 1,678

  6. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gerasimos Aravantinos, Norbert Arnold, Banu Arun, Brita Arver, Jacopo Azzollini, Judith Balmañà, Susana Banerjee, Laure Barjhoux, Rósa B. Barkardóttir, Yukie T. Bean, Matthias W Beckmann, Alicia Beeghly-Fadiel, Javier Benı́tez, Marina Bermisheva, Marcus Q. Bernardini, Michael J. Birrer, Line Bjorge, Amanda Black, Kenneth B. Blankstein, Marinus J. Blok, Clara Bodelón, Natalia Bogdanova, Anders Bojesen, Bernardo Bonanni, Åke Borg, Angela R. Bradbury, James D. Brenton, Carole Brewer, Louise A. Brinton, Per Broberg, Angela Brooks‐Wilson, Fiona Bruinsma, Joan Brunet, Bruno Buecher, Ralf Butzow, Saundra S. Buys, Trinidad Caldés, Maria A. Caligo, Ian Campbell, Rikki Cannioto, Michael E. Carney, Terence Cescon, Salina B Chan, Jenny Chang-Claude, Stephen J. Chanock, Xiao Qing Chen, Yoke-Eng Chiew, Jocelyne Chiquette, Wendy K. Chung, Kathleen Claes, Thomas Conner, Linda S. Cook, Jackie Cook, Daniel W. Cramer, Julie M. Cunningham, Aimee A. D’Aloisio, Mary B Daly, Francesca Damiola, Sakaeva Dina Damirovna, Agnieszka Dansonka‐Mieszkowska, Fanny Dao, Rosemarie Davidson, Anna DeFazio, Capucine Delnatte, Kimberly F. Doheny, Orland Dı́ez, Yuan Chun Ding, Jennifer A. Doherty, Susan M. Domchek, Cecilia M. Dorfling ほか 320 名 - Nature Genetics 2017 被引用: 553

  7. Cancer Risks Associated With GermlinePALB2Pathogenic Variants: An International Study of 524 Families

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antoine De Pauw, Orland Dı́ez, Jill S. Dolinsky, Susan M. Domchek, Christoph Engel, D. Gareth Evans, Florentia Fostira, Judy E. Garber, Lisa Golmard, Ellen L. Goode, Stephen B. Gruber, Eric Hahnen, Christopher R. Hake, Tuomas Heikkinen, Judith Hurley, Ramūnas Janavičius, Zdeněk Kleibl, Petra Kleiblová, Irene Konstantopoulou, Anders Kvist, Holly LaDuca, Ann S. G. Lee, Fabienne Lesueur, Eamonn R. Maher, Arto Mannermaa, Siranoush Manoukian, Rachel McFarland, Wendy McKinnon, Alfons Meindl, Kelly Metcalfe, Nur Aishah Mohd Taib, Jukka S. Moilanen, Katherine L. Nathanson, Susan L. Neuhausen, Pei Sze Ng, Tú Nguyen‐Dumont, Sarah M. Nielsen, Florian Obermair, Kenneth Offit, Olufunmilayo I. Olopade, Laura Ottini, Judith Penkert, Katri Pylkäs, Paolo Radice, Susan J. Ramus, Vilius Rudaitis, Lucy Side, Rachel Silva‐Smith, Valentina Silvestri, Anne‐Bine Skytte, Thomas Slavin, Jana Soukupová, Carlo Tondini, Alison H. Trainer, Gary Unzeitig, Lydia Usha, Thomas van Overeem Hansen, James Whitworth, Marie Wood, Cheng Har Yip, Sook‐Yee Yoon, Amal Yussuf, George Zogopoulos, David E. Goldgar, John L. Hopper, Georgia Chenevix‐Trench, Paul D.P. Pharoah, Sophia George, Judith Balmañà, Claude Houdayer ほか 19 名 - Journal of Clinical Oncology 2019 被引用: 418

  8. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , , , - Annals of Oncology 2022 被引用: 276

  9. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Olivier Déas, Jos Jonkers, Jean‐Yves Masson, Stefano Cairo, Jean‐Gabriel Judde, Mark J. O’Connor, Orland Dı́ez, Judith Balmañà, Violeta Serra - EMBO Molecular Medicine 2018 被引用: 274

  10. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jamie Allen, Christine B. Ambrosone, Christopher I. Amos, Irene L. Andrulis, Hoda Anton‐Culver, Natalia Antonenkova, Volker Arndt, Norbert Arnold, Kristan J. Aronson, Bernd Auber, Paul L. Auer, Margreet G.E.M. Ausems, Jacopo Azzollini, François Bacot, Judith Balmañà, Monica Barile, Laure Barjhoux, Rósa B. Barkardóttir, Myrto Barrdahl, Daniel R. Barnes, Daniel Barrowdale, Caroline Baynes, Matthias W. Beckmann, Javier Benı́tez, Marina Bermisheva, Leslie Bernstein, Yves‐Jean Bignon, Kathleen R. Blazer, Marinus J. Blok, Carl Blomqvist, William J. Blot, Kristie Bobolis, Bram Boeckx, Natalia Bogdanova, Anders Bojesen, Stig E. Bojesen, Bernardo Bonanni, Anne‐Lise Børresen‐Dale, Anikó Bozsik, Angela R. Bradbury, Judith S. Brand, Hiltrud Brauch, Hermann Brenner, Brigitte Bressac–de Paillerets, Carole Brewer, Louise A. Brinton, Per Broberg, Angela Brooks‐Wilson, Joan Brunet, Thomas Brüning, Barbara Burwinkel, Saundra S. Buys, Jinyoung Byun, Qiuyin Cai, Trinidad Caldés, Maria A. Caligo, Ian Campbell, Federico Canzian, Olivier Caron, Ángel Carracedo, Brian D. Carter, Jose E. Castelao, Laurent Castéra, Virginie Caux‐Moncoutier, Salina Chan, Jenny Chang‐Claude, Stephen J. Chanock, Xiaoqing Chen, Ting‐Yuan David Cheng, Jocelyne Chiquette ほか 376 名 - Nature Genetics 2017 被引用: 471

  11. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karin Jordan, Andrey Meshcheryakov, Demetris Papamichail, Per Pfeiffer, Ioannis Souglakos, Serdar Turhal, Andrés Cervantes - Annals of Oncology 2012 被引用: 1,534

  12. The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Valentina Fornerone, Paola Gabaldi, Felix Haglund, Johan Hartman, Peter Horak, Tanja Jutzi, Mary Kasanicki, Simon Kreutzfeldt, Lucian Le Cornet, Rolf Lewensohn, Johan Lindberg, Carlos López, Andreas Lundqvist, Jose‐Ezequiel Martín, Gerrit A. Meijer, Susana Muñoz, Maud Ngo Camus, Claudio Nicotra, Paolo Nucíforo, Petra Oberrauch, Päivi Östling, Laura Pelz, Alejandro Piris‐Giménez, Elena Provenzano, Étienne Rouleau, John Rowell, Omar Saavedra, Giovanni Scoazec, Kenneth B. Seamon, Marc Tischkowitz, Lizet van der Kolk, Ruud van der Noll, María Vieito, Daniël J. Vis, Ana Vivancos, Christina von Gertten, Anders Wennborg, Lodewyk F.A. Wessels, Valtteri Wirta, Judith Balmañà, Giovanni Apolone, Carlos Caldas, Jonas Bergh, Ingemar Ernberg, Stefan Fröhling, Elena Garralda, Claes Karlsson, Josep Tabernero, Emile E. Voest, Jordi Rodón, Janne Lehtiö - Nature Cancer 2022 被引用: 130

  13. Olaparib monotherapy as primary treatment in unselected triple negative breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2020 被引用: 226

  14. The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David L. Wiest, Denise C. Connolly, Mary B. Daly, Elizabeth M. Swisher, Peter Bouwman, Jos Jonkers, Judith Balmañà, Violeta Serra, Neil Johnson - Cancer Research 2016 被引用: 271

  15. Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy

    著者: , , , , , , , - Journal of Clinical Oncology 2019 被引用: 198

  16. Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    著者: , , , , , , - Annals of Oncology 2019 被引用: 251

  17. Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joaquı́n Mateo, Joaquı́n Arribas, Rodrigo Dienstmann, Meritxell Bellet, Mafalda Oliveira, Cristina Saura, Sara Gutiérrez‐Enríquez, Judith Balmañà, Violeta Serra - Cancer Research 2022 被引用: 97

  18. Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2021 被引用: 101

  19. Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Natalia Lukashchuk, Michael O. Dorschner, Leylah Drusbosky, Ioannis Roxanis, Violeta Serra, Syed Haider, Stephen J. Pettitt, Christopher J. Lord, Andrew Tutt - Annals of Oncology 2024 被引用: 71

  20. Abstract CT007: PETRA: First in class, first in human trial of the next generation PARP1-selective inhibitor AZD5305 in patients (pts) with BRCA1/2, PALB2 or RAD51C/D mutations

    著者: , , , , , , , , , , , , , , , - Cancer Research 2022 被引用: 70

  21. Early-Stage Breast Cancer Detection in Breast Milk

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2023 被引用: 58

  22. CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2016 被引用: 286

  23. Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Lee, Joe Dennis, David D.L. Bowtell, Nadia Traficante, Orland Dı́ez, Judith Balmañà, Stephen B. Gruber, Georgia Chenevix‐Trench, kConFab Investigators, Allan Jensen, Susanne K. Kjær, Estrid Høgdall, Laurent Castéra, Judy E. Garber, Ramūnas Janavičius, Ana Osório, Lisa Golmard, Ana Vega, Fergus J. Couch, Mark E. Robson, Jacek Gronwald, Susan M. Domchek, Julie O. Culver, Miguel de la Hoya, Douglas F. Easton, William D. Foulkes, Marc Tischkowitz, Alfons Meindl, Rita K. Schmutzler, Paul D.P. Pharoah, Antonis C. Antoniou - JNCI Journal of the National Cancer Institute 2020 被引用: 165

  24. The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Genome Medicine 2024 被引用: 62